Topics
.jpg%3Fwidth%3D300&w=3840&q=75)
thyroid cancerDisease
The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (DTC) is already approved, however its application in 131I therapy is still to be evaluated. We report results obtained in four patients with DTC metastatic to central skeleton, in whom 5 courses of rtTSH aided 131I therapy were administered
We report on a high-dose radioiodine therapy after injection of recombinant human thyrotropin (rhTSH...
Thyroid cancer is the most common endocrine malignancy. More than 90% of primary thyroid cancers are...
Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating h...
The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (...
Traditionally, withdrawal of thyroid hormone to increase serum levels of thyroid-stimulating hormone...
BACKGROUND: Periodic evaluation of serum thyroglobulin (Tg) and whole body 131I imaging ( 131I-WBS) ...
Traditionally, the immediate treatment of patients with differentiated thyroid carcinoma (DTC) after...
Recombinant human TSH (rhTSH) is an effective and safe alternative to thyroid hormone withdrawal dur...
The purpose of this work was to gain clinical experience with and to identify the optimal conditions...
Abstract The published studies confirming the safety and efficacy of rhTSH for diagnostic purposes h...
Recombinant human TSH in the diagnosis and treatment of disseminated differentiated thyroid cance
The clinical benefits of recombinant human thyroid-stimulating hormone (rhTSH; Thyrogen (R), Genzyme...
UNLABELLED: The follow-up of differentiated thyroid cancer (DTC) is currently performed by serum Tg ...
Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for preparation of t...
The follow-up of differentiated thyroid cancer (DTC) is currently performed by serum Tg levels deter...
We report on a high-dose radioiodine therapy after injection of recombinant human thyrotropin (rhTSH...
Thyroid cancer is the most common endocrine malignancy. More than 90% of primary thyroid cancers are...
Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating h...
The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (...
Traditionally, withdrawal of thyroid hormone to increase serum levels of thyroid-stimulating hormone...
BACKGROUND: Periodic evaluation of serum thyroglobulin (Tg) and whole body 131I imaging ( 131I-WBS) ...
Traditionally, the immediate treatment of patients with differentiated thyroid carcinoma (DTC) after...
Recombinant human TSH (rhTSH) is an effective and safe alternative to thyroid hormone withdrawal dur...
The purpose of this work was to gain clinical experience with and to identify the optimal conditions...
Abstract The published studies confirming the safety and efficacy of rhTSH for diagnostic purposes h...
Recombinant human TSH in the diagnosis and treatment of disseminated differentiated thyroid cance
The clinical benefits of recombinant human thyroid-stimulating hormone (rhTSH; Thyrogen (R), Genzyme...
UNLABELLED: The follow-up of differentiated thyroid cancer (DTC) is currently performed by serum Tg ...
Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for preparation of t...
The follow-up of differentiated thyroid cancer (DTC) is currently performed by serum Tg levels deter...
We report on a high-dose radioiodine therapy after injection of recombinant human thyrotropin (rhTSH...
Thyroid cancer is the most common endocrine malignancy. More than 90% of primary thyroid cancers are...
Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating h...
Add to ORKG